Also trades as: 4552.T (JPX) · $vol 2M

$3.60

+0.27 (+8.11%)

Weekly Expected Move ±5.2%

$3 $3 $4 $4 $4

OTC · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 58 · $439.3M mcap · 69M float · 0.0008% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$40.6B +22.7% ▲

5Y CAGR: +6.2%

Gross Profit

$30.2B +39.2% ▲

5Y CAGR: +6.3%

Operating Income

$434M +106.5% ▲

5Y CAGR: -44.5%

Net Income

$2.2B +146.1% ▲

5Y CAGR: -20.5%

EPS (Diluted)

$17.58 +145.7% ▲

5Y CAGR: -20.5%

EBITDA

$3.0B +204.2% ▲

5Y CAGR: -22.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$51.1B	$34.3B	$42.9B	$33.1B	$40.6B
YoY Growth	+69.8%	-32.8%	+24.8%	-22.9%	+22.7%
Cost of Revenue	$10.5B	$8.9B	$11.6B	$11.3B	$10.3B
Gross Profit	$40.6B	$25.5B	$31.3B	$21.7B	$30.2B
Gross Margin	79.5%	74.1%	72.9%	65.7%	74.6%
R&D Expenses	$7.2B	$8.8B	$11.2B	$0	$16.9B
SG&A Expenses	$13.5B	$11.7B	$12.5B	$0	$12.9B
Operating Expenses	$20.7B	$20.5B	$23.7B	$28.4B	$29.8B
Operating Income	$19.9B	$5.0B	$7.5B	-$6.7B	$434M
Operating Margin	39.0%	14.5%	17.6%	-20.1%	1.1%
Interest Expense	$45M	$44M	$86M	$155M	$401M
Income Before Tax	$19.4B	$5.4B	$7.2B	-$6.4B	$3.2B
Tax Expense	$4.9B	$1.6B	$1.7B	-$1.7B	$1.0B
Net Income	$14.5B	$3.8B	$5.5B	-$4.8B	$2.2B
Net Margin	28.4%	11.0%	12.8%	-14.4%	5.4%
EPS (Diluted)	$116.79	$30.22	$43.92	$-38.43	$17.58
EBITDA	$21.4B	$7.5B	$10.5B	-$2.9B	$3.0B
Shares Outstanding	124M	125M	125M	124M	122M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$8.1B	$8.5B	$9.2B	$7.2B	$59M	$13.0B	$9.0B	$10.0B
Cost of Revenue	$2.3B	$2.3B	$2.7B	$4.3B	$17M	$2.0B	$2.5B	$3.4B
Gross Profit	$5.9B	$6.3B	$6.5B	$2.9B	$43M	$10.9B	$6.5B	$6.6B
Gross Margin	71.9%	73.5%	71.0%	39.8%	72.1%	84.3%	72.4%	66.1%
R&D Expenses	$0	$0	$0	$15.4B	$23M	$4.6B	$5.5B	$3.4B
SG&A Expenses	$6.4B	$6.7B	$6.6B	$6.7B	$6.8B	$3.4B	$3.0B	$3.1B
Operating Expenses	$6.4B	$6.7B	$6.6B	$8.8B	$47M	$8.0B	$8.5B	$6.5B
Operating Income	-$510M	-$443M	-$15M	-$5.9B	-$4M	$3.0B	-$2.0B	$117M
Operating Margin	-6.3%	-5.2%	-0.2%	-82.0%	-7.5%	23.0%	-22.1%	1.2%
Interest Expense	$26M	$37M	$0	$30M	$17M	$79M	$151M	$91M
Income Before Tax	$369M	-$925M	$238M	-$6.1B	-$5M	$3.3B	$231M	$455M
Tax Expense	$164M	-$40M	$36M	$1.9B	-$1M	$1.0B	$142M	$42M
Net Income	$201M	-$891M	$115M	-$4.2B	-$546M	$2.3B	$34M	$438M
Net Margin	2.5%	-10.5%	1.2%	-58.2%	-918.3%	17.6%	0.4%	4.4%
EPS (Diluted)	$1.61	$-7.15	$0.93	$-34.28	$-4.48	$18.76	$0.28	$3.58
EBITDA	$1.2B	-$163M	$739M	-$5.1B	$200M	$4.1B	$944M	$659M
Shares Outstanding	125M	125M	122M	122M	122M	122M	122M	122M

JCRRF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet